Ajanta Pharma has target of Rs 165: Gujral

Published on Thu, Jan 21, 2010 at 08:55 |  Source : CNBC-TV18

Updated at Thu, Jan 21, 2010 at 09:58  

3758 Investors following Ajanta Pharma. Share this News with them.
0
0
Share on Tumblr
Ashwani Gujral, Technical Analyst

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Ajanta Pharma has target of Rs 165, says Technical Analyst, Ashwani Gujral .

Gujral told CNBC-TV18, "The smaller pharmaceutical stocks tend to do better when the market is kind of choppy. So we could buy Ajanta Pharma with a stoploss of Rs 125. It had a breakout yesterday; it could see targets of Rs 165."

Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stocks/sector.

  

Entities: Ashwani Gujral
More on Moneycontrol

Trending News

Business News

Government to directly check BBM and other IM services
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com